BioSpace News Archive

Renovacor, Inc. today announced the appointment of Matt Killeen, Ph.D., as chief scientific officer (CSO), effective as of September 1, 2021.

FibroGen, Inc. (NASDAQ: FGEN) today announced positive topline results from WHITNEY, the Company’s Phase 2 clinical study of roxadustat, a first-in-class oral small molecule hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI)

Helius Medical Technologies, Inc. today announced that it has provided written notice to the Toronto Stock Exchange (the “TSX”) regarding the voluntary delisting of its Class A common stock from the TSX.

Blade Therapeutics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has activated the Company’s Investigational New Drug (IND) application to investigate cudetaxestat in IPF.

Recordati Rare Diseases Inc. is pleased to welcome William Ludlam, MD, PhD, in the role of Chief Medical Officer and Vice President - Clinical Development.

Taysha Gene Therapies, Inc. today announced that it has been granted orphan drug designation from the European Commission for TSHA-105, an AAV9-based gene therapy in development for SLC13A5-related epilepsy.

Achilles Therapeutics plc (NASDAQ: ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that US patent US 11,098,121 and European patent EP3347039B have been granted.

TetraScience announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers.

Zalgen Labs LLC, a biotechnology and diagnostics company focused on preparedness for high impact, neglected infectious diseases including Lassa Fever, announced its contract with the Coalition for Epidemic Preparedness Innovations to further advance the development of vaccines against Lassa Fever in West Africa, a region where the disease is endemic.

Scout Clinical today announced the results of their rare disease clinical trial patient focus group.